85-2073-23 GSK-3 Inhibitor IX ((2’Z,3’E)-6-Bromoindirubin-3’-oxime) 1mg 217401
特徴
- A cell-permeable bis-indolo (indirubin) compound that acts as a highly potent, selective, reversible, and ATP-competitive inhibitor of GSK-3a/b (IC50=5nM). Its specificity has been tested against various Cdk's (IC50=83, 300, 320, and 10,000nM for Cdk5/p25, Cdk2/A, Cdk1/B, and Cdk4/D1, respectively) as well as many other commonly studied kinases (IC50≥10uM), including MAP kinases, PKA, PKC isoforms, PKG, CK, and IRTK. Inhibition of GSK by BIO has been shown to result in the activation of Wnt-signaling pathway and sustained pluripotency in human and murine ESCs (embryonic stem cells). Reported to maintain self-renewal in human and mouse embryonic stem cells. Also induces the differentiation of neonatal cardiomyocytes.
- Formula:C16H10BrN3O2
- Primary Target:GSK-3a/b
- Primary Target IC50:5nM
- Secondary Target:IC50 = 83, 300, 320, and 10,000nM for Cdk5/p25, Cdk2/A, Cdk1/B, and Cdk4/D1, respectively.
- Solubility:DMSO
- Molecular Weight:356.2
- Storage and Stability:May be stored at 4°C. For long-term storage, aliquot and store at 4°C. Do not freeze. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.
仕様
- Size:1mg
- Grade:Highly Purified
- Purity:~97% (HPLC)
- Form:Supplied as a purple solid.
- Molecular Formula:C16H10BrN3O2
- Molecular Weight Non Ab:356.2
- EU Commodity Code:38220090
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]
商品のバリエーション (サイズ違い・スペック違い・オプション品など)
| 商品イメージ | アズワン品番 商品名 |
|---|---|
|
85-2073-23
GSK-3 Inhibitor IX ((2’Z,3’E)-6-Bromoindirubin-3’-oxime) 1mg
|
|
|
85-2073-24
GSK-3 Inhibitor IX ((2’Z,3’E)-6-Bromoindirubin-3’-oxime) 10mg
|
よくあるご質問(FAQ)
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|





